 |
|
Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study
Jung-Yoon Heo, Hawoo Yi, Maurizio Fava, David Mischoulon, Kiwon Kim, Sechang Yoon, Hong Jin Jeon, Jeong Eon Lee
Psychiatry Investig. 2017;14(4):491-498. Published online 2017 Jul 11 DOI: https://doi.org/10.4306/pi.2017.14.4.491
|
|
In silico
studies, synthesis, characterization and
in vitro
studies of levosulpiride derivatives
Muhammad Toseef Akram, Mohsin Abbas Khan, Irshad Ahmad, Farhat Ullah, Muhammad Rizwan Khan, Zarmeena Yasmeen, Khalil Ahmad, Breena Breena
Future Medicinal Chemistry.2024; 16(23): 2459. CrossRef Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer
Kim Tam Bui, Melina L Willson, Shom Goel, Jane Beith, Annabel Goodwin
Cochrane Database of Systematic Reviews.2020;[Epub] CrossRef Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
Mariam Abotaleb, Peter Kubatka, Martin Caprnda, Elizabeth Varghese, Barbora Zolakova, Pavol Zubor, Radka Opatrilova, Peter Kruzliak, Patrik Stefanicka, Dietrich Büsselberg
Biomedicine & Pharmacotherapy.2018; 101: 458. CrossRef
|